Where Innovation Meets Impact

At SARKKOS Therapeutics, we are an early-stage biotech startup. Our mission is clear: “We aim to develop innovative, small-molecule targeted anti-tumour therapies that address the unique biological challenges of obesity-related solid cancers”. With a core team, we focus on rapid innovation, strategic partnerships, and transformative science.

We believe that groundbreaking ideas thrive in focused environments and through long-term partnerships and collaborations. In the biotechnology sector, no single company—no matter how innovative—can succeed in isolation; meaningful progress and impact require collaboration, partnerships, and a shared ecosystem. By joining forces with visionary investors and partners, we are poised to deliver not only scientific breakthroughs but also significant medical benefits for patients suffering from obesity-related solid cancers.